Another surrogate marker for distinguishing luminal A-like from luminal B-like breast cancers, progesterone receptor expression, is also an independent prognostic factor for HR+/HER2- breast cancer, particularly in premenopausal women [10, 16]. Here, ERBB2 is linked to breast cancer.